Leukaemia Foundation to support award for world leading haematologists
Wednesday 21 August 2019
Two world leaders in haematology will receive awards supported by the Leukaemia Foundation at this year’s International Society of Experimental Haematology Honorific (ISEH) meeting this week.
Dr David Scadden and Dr David Traver will be presented at ISEH’s Annual Scientific Meeting to be held in Brisbane from
Million-dollar investment into incurable blood cancer announced as Light the Night launches this week
Tuesday 6 August 2019
The Leukaemia Foundation will unveil a million-dollar investment into Strategic Ecosystem Research Partnership (SERP) grants which will use new state-of-the-art immunotherapy techniques, new drug design and molecular technology to understand the mechanisms of relapse and continue to drive rapid advancements in treatments for the incurable blood cancer, myeloma.
CAR-T therapy now accessible in Victoria for young Australians with acute lymphoblastic leukaemia at no cost
Monday 5 August 2019
The Leukaemia Foundation has welcomed the announcement by Federal Health Minister Greg Hunt and Victorian Minister for Health Jenny Mikakos to collaborate and co-fund CAR-T therapy in Victoria. The treatment will be available immediately and at no cost for paediatric and young adult patients up to 25 years of age with B-cell precursor acute lymphoblastic leukaemia (ALL) that
Inaugural Life Ride cycling fundraiser comes to Margaret River
Thursday 1 August 2019
The Leukaemia Foundation and Tour de Cure will combine forces in 2019 to host the first Life Ride – an inspiring three-day cycling event to help fund research and find a cure for blood cancer.
The inaugural Life Ride will be held in the spectacular Margaret River region
Leukaemia Foundation supports Health Minister in PBS announcement for dasatinib
Sunday 28 July 2019
Australians who are newly diagnosed with an aggressive leukaemia will now have access to the drug dasatinib following an announcement by Federal Health Minister Greg Hunt this week.
Dasatinib, a drug that is used in the treatment of several types of leukaemia, will now be available to
Joint funding partnership bolsters Australian blood cancer research
Thursday 18 July 2019
Australian research will benefit from a new partnership between US-based The Leukemia & Lymphoma Society (LLS) and two Australian organisations, Snowdome Foundation and Leukaemia Foundation.
The Snowdome Foundation and Leukaemia Foundation have joined forces with America’s The Leukemia & Lymphoma Society (LLS) to fund four blood cancer research projects with Australian researchers through the LLS Translational
New score to help navigate improved treatment for follicular lymphoma patients
Friday 12 July 2019
More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to funding from the Leukaemia Foundation.
The Leukaemia Foundation will support Brisbane-based researcher Professor Maher Gandhi to design a new genetic, immune and clinical prognostic score to
Roll up your sleeves regularly to support blood cancer patients
Monday, 10 June 2019
The Leukaemia Foundation is challenging more Australians to step up and become one of the 18 monthly blood donors it takes to treat just one person living with blood cancer this National Blood Donor Week.
More than 100,000 Australians are currently affected by blood cancer, and Leukaemia
Leukaemia Foundation celebrates National Volunteer Week 2019
Volunteer drivers who take blood cancer patients to and from vital medical appointments last year travelled more than 1.5 million kilometres, the equivalent of driving 37 times around the world.
It’s a service the Leukaemia Foundation’s General Manager of People Living with Blood Cancer Emma Craig said could not be
Leukaemia Foundation supports Australian Research Innovation
The Leukaemia Foundation has confirmed it will fund priority-driven blood cancer research in some of Australia’s leading research centres through an $800,000 grant to Cancer Australia.
Five innovative projects will benefit from the funding through the Leukaemia Foundation’s ongoing partnership with Cancer Australia – an Australian Government agency that provides